NCT04919317View on ClinicalTrials.gov

Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 29, 2017

Primary Completion Date

November 7, 2020

Study Completion Date

November 25, 2020

Conditions
Pain, PostoperativeMammaplasty
Interventions
DRUG

Dexamethasone 4mg

The experimental group received 4mg dexamethasone added to their bupivacaine block preoperatively just prior to bilateral reduction mammaplasty.

DRUG

Saline

The control group received 1mL of 0.9% saline added to their bupivacaine block preoperatively just prior to bilateral reduction mammaplasty.

Trial Locations (1)

19140

Temple University Hospital, Philadelphia

All Listed Sponsors
lead

Temple University

OTHER

NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty | Biotech Hunter | Biotech Hunter